Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19

NCT04354259 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

157

Enrollment

OTHER

Sponsor class

Conditions

Sars-CoV2
Covid-19

Interventions

DRUG: Peginterferon Lambda-1A
OTHER: placebo

Sponsor

University Health Network, Toronto

Collaborators

[object Object]